Literature DB >> 18059255

Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient.

C Tascini1, L Urbani, G Biancofiore, G M Rossolini, A Leonildi, G Gemignani, M L Bindi, C Mugnaioli, F Filipponi, F Menichetti.   

Abstract

A case of bla(VIM-1) producing E. cloacae disseminated infection in a patient submitted to orthotopic liver transplantation is described. Synergism between colistin, rifampin and imipenem was studied in vitro and this combination of three drugs was used to treat E. cloacae infection. The synergistic activity of this combination was demonstrated showing an increased activity of the serum bactericidal activity in comparison with the bactericidal activity of the serum taken during the previous therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059255

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  4 in total

1.  Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium.

Authors:  Song Sun; Aurel Negrea; Mikael Rhen; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

Review 2.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

Review 3.  Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems.

Authors:  Oren Zusman; Tomer Avni; Leonard Leibovici; Amos Adler; Lena Friberg; Theodouli Stergiopoulou; Yehuda Carmeli; Mical Paul
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

4.  Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients.

Authors:  A J Mathers; H L Cox; H Bonatti; B Kitchel; A K C Brassinga; B Wispelwey; R G Sawyer; T L Pruett; K C Hazen; J B Patel; C D Sifri
Journal:  Transpl Infect Dis       Date:  2009-02-18       Impact factor: 2.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.